Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antivirals for influenza].

Paul Leophonte1

  • 1Clinique des Voies Respiratoires, Hopital Larrey, 24, Chemin de Pouvourville, TSA 30030-31059 Toulouse.

Bulletin De L'Academie Nationale De Medecine
|August 24, 2005
PubMed
Summary

This review covers antivirals for influenza, including adamantanes, ribavirin, and neuraminidase inhibitors. Neuraminidase inhibitors are highlighted for their effectiveness against influenza A and B with minimal resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[3<sup>e</sup> Conférence européenne sur la grippe, et XXI<sup>es</sup> Rencontres européennes de prévention et contrôle de la grippe].

Virologie (Montrouge, France)·2022
Same author

Efficiency of a phone coaching program on adherence to continuous positive airway pressure in sleep apnea hypopnea syndrome: a randomized trial.

BMC pulmonary medicine·2015
Same author

[Sleep apnea syndromes and cardiovascular disease].

Bulletin de l'Academie nationale de medecine·2005
Same author

[Infections in chronic obstructive pulmonery disease].

Bulletin de l'Academie nationale de medecine·2004
Same author

[Broncho-pulmonary infections in the adult].

La Revue du praticien·2004
Same author

[Community acquired pneumonia: higher mortality than traffic accidents ].

La Revue du praticien·2003

Area of Science:

  • Virology
  • Pharmacology

Context:

  • Influenza viruses pose a significant public health threat, necessitating effective therapeutic strategies.
  • Antiviral medications are crucial for managing influenza, particularly during inter-pandemic and pandemic periods.

Purpose:

  • To review antivirals active against Myxovirus influenzae (influenza virus).
  • To discuss the indications for these antivirals in inter-pandemic and pandemic situations.

Summary:

  • Three classes of antivirals are effective against influenza: adamantanes (amantadine, rimantadine), ribavirin, and neuraminidase inhibitors (zanamivir, oseltamivir).
  • Amantadine has limited use due to resistance and inactivity against influenza B. Ribavirin is for severe cases. Neuraminidase inhibitors are effective, well-tolerated, and active against influenza A and B with low resistance rates.
  • Antivirals can be used during epidemics and pandemics, but not as a substitute for vaccination. Supply and treatment prioritization are key concerns during pandemics.

Impact:

  • Provides a comprehensive overview of current influenza antiviral therapies.
  • Informs clinical decision-making for influenza treatment and pandemic preparedness.
  • Highlights the importance of neuraminidase inhibitors and addresses limitations of other antivirals.

Related Experiment Videos